Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Development of the Lymphatic System01:15

Development of the Lymphatic System

1.2K
The development of lymphatic tissues and vessels in embryonic life begins around the fifth week. These structures originate from the mesoderm layer, with lymph sacs emerging from developing veins.
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
1.2K
Tumor Progression02:07

Tumor Progression

6.6K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.6K
Lymphatic Vessels and Lymph Transport01:16

Lymphatic Vessels and Lymph Transport

15.4K
Lymphatic vessels, known as lymphatics, are crucial in transporting lymph from peripheral tissues to our venous system. This process begins with lymph entering through tiny capillaries that branch through tissues. These capillaries have unique features such as larger diameters, thinner walls, and a distinctive one-way valve system formed by overlapping endothelial cells.
This one-way system allows fluids, solutes, and even pathogens to enter but prevents their return to the intercellular...
15.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of total sedentary behaviour and television viewing with risk of overweight/obesity, type 2 diabetes and hypertension: A dose-response meta-analysis.

Diabetes, obesity & metabolism·2019
Same author

AAV-ie enables safe and efficient gene transfer to inner ear cells.

Nature communications·2019
Same author

The effect of the overexpression of miR-490 on the biological function of prostate cancer cell PC-3.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology·2019
Same author

Treatment response and outcome of children with T-cell acute lymphoblastic leukemia expressing the gamma-delta T-cell receptor.

Oncoimmunology·2019
Same author

Hypertension is a modifiable risk factor for osteonecrosis in acute lymphoblastic leukemia.

Blood·2019
Same author

Patients' experiences of coping with multiple chronic conditions: A qualitative descriptive study.

Journal of clinical nursing·2019
Same journal

Establishment of a CT-based prediction model for endotracheal tube size in infants aged <1 year.

Frontiers in pediatrics·2026
Same journal

Case Report: Subcutaneous sensor-augmented insulin pump therapy in a 510-g preterm infant with hyperglycemia.

Frontiers in pediatrics·2026
Same journal

Association between glucolipid metabolic indicators and the risk of suspected precocious puberty in children living with obesity: a retrospective cohort study.

Frontiers in pediatrics·2026
Same journal

Clinical and imaging features of tufted angioma in children.

Frontiers in pediatrics·2026
Same journal

Transcriptome-Inferred metabolic subtypes define prognostic and immune ecosystems in osteosarcoma at single-cell resolution.

Frontiers in pediatrics·2026
Same journal

Efficacy and anthropometric predictors of negative-pressure therapy for recurrent concealed penis in pediatric patients.

Frontiers in pediatrics·2026
See all related articles

Related Experiment Video

Updated: Oct 8, 2025

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
07:36

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting

Published on: May 1, 2015

14.5K

Recent Progress in Lymphangioma.

Xiaowei Liu1,2, Cheng Cheng1,2, Kai Chen1,2

  • 1Department of Pediatric Surgery, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.

Frontiers in Pediatrics
|January 3, 2022
PubMed
Summary
This summary is machine-generated.

Lymphangioma, a common congenital vascular anomaly in children, requires better classification. Research is advancing to molecular pathology for targeted therapies and improved outcomes.

Keywords:
classificationlymphangiomamolecular biologyprecision medicinesignaling pathway

More Related Videos

A Murine Tail Lymphedema Model
04:38

A Murine Tail Lymphedema Model

Published on: February 10, 2021

6.1K
A Patient-Derived Xenograft Model for Venous Malformation
06:51

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

5.5K

Related Experiment Videos

Last Updated: Oct 8, 2025

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
07:36

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting

Published on: May 1, 2015

14.5K
A Murine Tail Lymphedema Model
04:38

A Murine Tail Lymphedema Model

Published on: February 10, 2021

6.1K
A Patient-Derived Xenograft Model for Venous Malformation
06:51

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

5.5K

Area of Science:

  • Pediatric vascular anomalies
  • Congenital diseases
  • Molecular pathology

Background:

  • Lymphangioma is a prevalent congenital vascular disease in children.
  • Current classifications based on clinical presentation are insufficient for treatment and prognosis.
  • Disease management and outcomes vary widely based on classification and location.

Purpose of the Study:

  • To highlight the limitations of current lymphangioma classification systems.
  • To emphasize the emerging role of molecular pathology in understanding lymphangioma.
  • To advocate for molecular-based classification for improved therapeutic strategies and prognosis.

Main Methods:

  • Review of current literature on lymphangioma classification and molecular pathology.
  • Analysis of signaling pathways implicated in lymphangioma development.
  • Investigation of existing drugs with potential anti-tumor effects in lymphangioma.

Main Results:

  • Existing classification systems are inadequate for guiding treatment and predicting outcomes.
  • Several signaling pathways are identified as crucial in lymphangioma progression.
  • Some drugs used for other conditions show efficacy, but mechanisms are unclear.

Conclusions:

  • Molecular classification is essential for developing individualized treatment strategies for pediatric lymphangioma.
  • Further research into molecular mechanisms will reduce side effects and improve treatment efficacy.
  • Understanding drug mechanisms is key to optimizing current therapies.